BioSpace News Archive

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported the exercise of warrants to purchase 1.2 million shares of SCYNEXIS common stock by Federated Hermes Kaufmann Small Cap Fund and Dafna Lifescience LP for which SCYNEXIS accepted a reduced exercise price. Proceeds to SCYNEXIS are approximately $7.9 million.

iZafe Group iZafe Group AB hereby announces that the first pharmaceutical robots adapted for the Italian consumer market have now been sent to Sempli Farma in Italy for the pilot project.

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research.

The global tissue imaging market size is projected to be worth USD 27.32 Billion by 2027, according to a current analysis by Emergen Research.

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has commenced a preclinical human study with researchers at the University of South Carolina.

The Metastatic Breast Cancer (MBC) Heroes™ recognition program is designed to honor individuals who have inspired change, exemplified compassion, or made a significant impact in the lives of those affected by metastatic breast cancer.

Stoke Therapeutics, Inc. today announced highlights from five presentations related to the ongoing clinical development of STK-001 being made at the American Epilepsy Society (AES) 2021 Annual Meeting, December 3 – 7.

Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA).

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services.